BiotechTube
Home/Atommap/Huafeng Xu, PhD
HX

Huafeng Xu, PhD

Founder and CEO

Atommap

Therapeutic Areas

Oncology

Atommap Pipeline

DrugIndicationPhase
Mutant KRAS ProgramOncology (KRAS-mutant cancers)Pre-clinical
SMARCA2 Degrader ProgramOncologyPre-clinical
Mutant-Selective Degrader ProgramOncology (unspecified mutant oncoprotein)Pre-clinical

Leadership Team at Atommap

JI
Jesus Izaguirre, PhD
Co-founder and Chief Computational Scientist
YW
Yujie Wu, PhD
Co-founder and Chief Technology Officer
CK
Cheryl Koh, PhD
Head of Discovery Biology
MH
Mandana Honu, PhD
Head of Business Development
AZ
Arie Zask, PhD
Head of Chemistry
View full Atommap profile